Lipella Pharmaceuticals announced the dosing of the first two patients with LP-310 in its Phase 2a clinical trial in Oral Lichen Planus, or OLP, patients.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LIPO: